8.2% overall MARD5
The lower the MARD, the more accurate the results
The only CGM sensor that maintains a high degree of accuracy through 15 days1
The ease of the FreeStyle Libre 2 system,2 now with 15-day sensor wear
Glucose readings every minute, sent right to your patients’ smartphones◊,¤
including strong low-end performance5
Allows for integrated experiences with insulin pumps
The FreeStyle Libre 2 Plus sensor is indicated for patients 2 years and older whereas the FreeStyle Libre 2 and FreeStyle Libre 3 sensors are indicated for patients 4 years and older.
8.2% overall MARD5
The lower the MARD, the more accurate the results
91% overall glucose readings within ±20%, exceeding strictest regulated standards for accuracy3-5
Outstanding accuracy in the low glucose range (<3.9 mmol/L)—98.9% within ±1.1 mmol/L5
Both sensors in the FreeStyle Libre 2 system have a high degree of clinical accuracy, with 99.9% of readings in Zones A and B of the Consensus Error Grid without the need for finger prick calibration.
A more convenient experience for your patients
Patients start their FreeStyle Libre 2 Plus sensor with the Omnipod 5 App,8 instantly connecting the sensor to the Omnipod 5 System—so it is ready to begin automated insulin delivery.9
| Unlike other CGMs, there's no need to switch out a FreeStyle Libre 2 Plus sensor midway through an Omnipod 5 use.10 |
Real-time glucose readings from the FreeStyle Libre 2 Plus sensor are automatically¤ updated every minute and sent directly to the FreeStyle LibreLink app◊ on your patients' smartphones.
Using LibreView,₼ our secure6 cloud-based system, patients can upload their data to share with their doctor and care team. You will be able to access more in-depth reports to support you in making treatment decisions for your patients.
With the free LibreLinkUp§ app, your patients’ family members get real-time accessǁ to their glucose information and customisable alarms.
Patients start their FreeStyle Libre 2 Plus sensor with the Omnipod 5 App,8 instantly connecting the sensor to the Omnipod 5 System—so it is ready to begin automated insulin delivery.9
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
Omnipod and the Omnipod logo are registered trademarks of Insulet Corporation and used with permission.
1. Data on file, Abbott Diabetes Care, Inc. Among leading brands based on market share.
2. Haak, T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6.
3. Based on FDA iCGM special controls. Accessed August 2023 from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=862.1355.
4. Adult cohort, N=149. Lower one-sided 95% confidence bound of the percentage of measurements within ±20% exceeds iCGM benchmark of 87%.
5. Data on file, Abbott Diabetes Care, Inc.
6. LibreView is ISO27001/27018/27701 certified and HITRUST CSF Certified
7. Alva, S. J Diabetes Sci Technol (2020): https://doi.org/10.1177/1932296820958754.
8. The Omnipod 5 App is available in the dedicated Controller.
9. An active Pod and a paired FreeStyle Libre 2 Plus sensor are required to swicth to Automated Mode. During sensor warm-up, the Omnipod 5 System will be in Automated: Limited state. When warm-up is complete and sensor glucose values are available, the Omnipod 5 System will enter Automated Mode, where the Pod uses sensor glucose values to make automated insulin dosing decisions every 5 minutes.
10. Based on up to 3 days of automated insulin delivery.
¤ Glucose readings are automatically displayed in the FreeStyle LibreLink app only when the smartphone and sensor are connected and in range.
◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
§ The LibreLinkUp app is only compatible with certain mobile devices and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
ǁ Sharing of glucose data requires registration with LibreView. The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
If you're a healthcare professional located in a different country, please select your country's website from the list of our global sites or contact your local Abbott representative for correct information about the products available in your country.
If you're not a healthcare profressional, click here to go to the FreeStyle Libre consumer website for the UK.
Stay connected